Veraxa Biotech Holding AG (VRXA) Total Current Liabilities (2024 - 2025)
Veraxa Biotech Holding AG (VRXA) posted quarterly Total Current Liabilities of $8.3 million for Q4 2025, up 184.71% year-over-year from $2.9 million in Q4 2024, and up 184.71% quarter-over-quarter from $2.9 million in Q4 2024.
Veraxa Biotech Holding AG (VRXA) Total Current Liabilities (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXA) has reported Total Current Liabilities for 2 consecutive years, with $8.3 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Current Liabilities rose 184.71% year-over-year to $8.3 million; the TTM figure through Dec 2025 stood at $8.3 million (up 184.71% YoY), while the FY2025 annual figure was $8.3 million, up 184.71% from the prior year.
- Total Current Liabilities advanced to $8.3 million in Q4 2025 per VRXA's latest filing, from $2.9 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $8.3 million in Q4 2025 and bottomed at $2.9 million in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.27 Mn |
| Dec 31, 2024 | 2.91 Mn |